Skip to content Skip to footer

Weekly Snapshot

PharmaShots Weekly Snapshots (January 27, 2025 – January 31, 2025)
This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, Biosimilars, Animal Health & DigiHealth. Check out our full report below:   Merck and Eisai Reveal Latest Data from P-III (LEAP-015) Trial of Keytruda (pembrolizumab) and Lenvima (lenvatinib) Regimen to Treat Gastroesophageal Adenocarcinoma Read More: Merck and Eisai Novo Nordisk Completes P-Ib/IIa Study…
PharmaShots Weekly Snapshots (January 20, 2025 – January 24, 2025)
This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, DigiHealth, MedTech, Biosimilars, Animal Health & Biotech. Check out our full report below:     Novo Nordisk Reports Headline Results from P-IIIb (STEP UP) Study of Semaglutide 7.2mg in Obese Adults without Diabetes Read More: Novo Nordisk Yoltech Initiates a Dose-Escalation Study for YOLT-204 to Treat…
PharmaShots Weekly Snapshots (January 13, 2025 – January 17, 2025)
This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, Biosimilars, Animal Health & Biotech. Check out our full report below:  Bayer Reports Topline Data from P-III (QUANTI) Trials of Gadoquatrane for its Use in MRIRead More: BayerOryzon Reports Dosing of the First Patient with Iadademstat + Venetoclax + Azacitidine…
PharmaShots Weekly Snapshots (January 06, 2025 – January 10, 2025)
This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, Biosimilars, Animal Health & Biotech. Check out our full report below:  Oculis Reports Results from P-II (ACUITY) Study of OCS-05 for Treating Acute Optic NeuritisRead More: OculisPharmaEssentia Reports Topline Data from P-III (SURPASS-ET) Trial of Ropeginterferon Alfa-2b-Njft (P1101) in Essential…
PharmaShots Weekly Snapshots (December 30th, 2024 – January 03rd, 2025)
This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, Biosimilars, Animal Health & Biotech. Check out our full report below:  Novartis Reports Data from P-III (STEER) Study of Onasemnogene Abeparvovec to Treat Children and Young Adults with Spinal Muscular Atrophy (SMA)Read More: NovartisCARsgen Therapeutics Reports Topline Results from P-II…

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]